Bromley v. Mentor Corporation et al
Filing
50
ORDER granting (45) Motion for Partial Summary Judgment in case 4:13-cv-00017-CDL; granting (29) Motion for Partial Summary Judgment in case 4:13-cv-00339-CDL; granting in part and denying in part (29) Motion for Partial Summary Judgment in case 4:13-cv-00464-CDL; granting (29) Motion for Partial Summary Judgment in case 4:13-cv-00485-CDL; granting in part and denying in part (27) Motion for Partial Summary Judgment in case 4:14-cv-00060-CDL; granting in part and denying in part (27) Motion for Partial Summary Judgment in case 4:14-cv-00062-CDL. Ordered by US DISTRICT JUDGE CLAY D LAND on 11/19/2015. (CGC)
IN THE UNITED STATES DISTRICT COURT
FOR THE MIDDLE DISTRICT OF GEORGIA
COLUMBUS DIVISION
IN RE MENTOR CORP. OBTAPE
*
TRANSOBTURATOR SLING PRODUCTS
*
LIABILITY LITIGATION
*
MDL Docket No. 2004
4:08-MD-2004 (CDL)
Case Nos.
4:13-cv-00017
4:13-cv-00339
4:13-cv-00464
4:13-cv-00485
4:14-cv-00060
4:14-cv-00062
*
*
(Bromley)
(Larranaga)
(Kaiser)
(Hill)
(Burt)
(Alexander)
*
O R D E R
Defendant Mentor Worldwide LLC developed a suburethral sling
product called ObTape Transobturator Tape, which was used to treat
women with stress urinary incontinence.
Plaintiffs Lisa Bromley,
Maria Larranaga, Marian Kaiser, Sandy Anne Hill, Barbara Burt, and
Leslie Alexander were implanted with ObTape and assert that they
suffered injuries caused by ObTape.
Each Plaintiff brought a
product liability action against Mentor, contending that ObTape
had design and/or manufacturing defects that proximately caused
her
injuries.
Plaintiffs
also
assert
that
Mentor
did
not
adequately warn their physicians about the risks associated with
ObTape.
Mentor
seeks
Plaintiffs’ claims.
partial
summary
partial
judgment
on
several
of
For the reasons set forth below, Mentor’s
judgment
Larranaga, and Hill.
summary
motions
are
granted
as
to
Bromley,
The motions are granted in part and denied
in part as to Kaiser, Burt, and Alexander.
SUMMARY JUDGMENT STANDARD
Summary judgment may be granted only “if the movant shows
that there is no genuine dispute as to any material fact and the
movant is entitled to judgment as a matter of law.”
P. 56(a).
Fed. R. Civ.
In determining whether a genuine dispute of material
fact exists to defeat a motion for summary judgment, the evidence
is
viewed
summary
in
the
judgment,
light
drawing
opposing party’s favor.
242,
255
most
(1986).
favorable
all
to
the
justifiable
party
opposing
inferences
in
the
Anderson v. Liberty Lobby, Inc., 477 U.S.
A fact
is
material
necessary to the outcome of the suit.
if
it
is
Id. at 248.
relevant or
A factual
dispute is genuine if the evidence would allow a reasonable jury
to return a verdict for the nonmoving party.
Id.
FACTUAL BACKGROUND
I.
Lisa Bromley (ECF No. 45 in 4:13-cv-17)
On October 18, 2005, Dr. Fawad Zafar implanted Bromley with
ObTape
to
treat
her
stress
urinary
incontinence.
In
2007,
Bromley’s husband began to experience comfort during sex, “like he
was hitting some type of plastic or something that was hard.”
Bromley Dep. 93:10-21, ECF No. 45-5.
The problem worsened, and
Bromley’s husband “said he could actually, you know, see [the
ObTape], that it was actually -- that it looked like it was not
supposed to be coming out, but it looked like it was -- you know,
it was falling apart.”
Id. at 96:20-97:7.
2
In September 2008, Bromley went to Dr. Priscilla Ruhe with
complaints of burning with urination.
At the time, according to
Bromley, “you could see the actual mesh falling out.”
106:14-18.
Id. at
Dr. Ruhe saw an exposed piece of ObTape in Bromley’s
vagina, and she told Bromley that “it looked like it was part of
the bladder sling” and “that it shouldn’t have been falling out.”
Id.
at
105:18-106:4.
material”
was
irritation.”
Dr.
“causing
Id.
portion of ObTape.
at
Ruhe
[Bromley]
told
Bromley
pain
107:15-23.
Dr.
in
that
the
Ruhe
the
vagina
removed
“excess
from
the
the
eroded
Bromley contends that she did not connect her
complications to ObTape until she consulted another doctor in 2011
and learned that the remainder of the ObTape would have to be
removed.
Bromley is an Iowa resident whose ObTape-related treatment
took place in Iowa.
She filed her action in Hennepin County
District Court of the State of Minnesota and served Mentor with
the Complaint on December 21, 2012.
Bromley brought claims for
strict liability and negligence.
II.
Maria Larranaga (ECF No. 29 in 4:13-cv-339)
Larranaga
saw
her
gynecologist,
Dr.
Steve
Vouis,
for
treatment of stress urinary incontinence.
Dr. Vouis implanted
Larranaga with ObTape on December 29, 2005.
Larranaga did not see
any materials from Mentor regarding ObTape, and she did not speak
with any representatives of Mentor about the product.
3
Larranaga
asserts that Mentor misrepresented to Dr. Vouis (or concealed from
him) an accurate complication rate for ObTape, the severity of
known ObTape complications, and true information about ObTape’s
physical characteristics.
She also contends that if Dr. Vouis had
known the true risks of ObTape, he would not have implanted it in
Larranaga.
But Larranaga did not point the Court to any evidence
on this point.1
Larranaga returned to Dr. Vouis in October 2008 complaining
of recurrent incontinence and dyspareunia.
connect
Larranaga’s
attributes
symptoms
several
with
Dr. Vouis did not
ObTape.
symptoms—including
Larranaga
dyspareunia,
currently
pain,
and
incontinence—to ObTape.
Larranaga
treatment
is
took
a
place
California
in
resident
California.
She
whose
ObTape-related
filed
her
action
in
Hennepin County District Court of the State of Minnesota on July
3,
2013.
negligence,
Larranaga
breach
of
brought
claims
express
for
warranty,
strict
breach
liability,
of
implied
warranty, common law fraud, constructive fraud, and negligent and
intentional misrepresentation.
1
Larranaga asserts that Dr. Vouis testified that he would not have used
ObTape if he had known of its true risks. Larranaga cites several pages
of Dr. Vouis’s deposition in support of these assertions (108, 119-121),
but she did not include those pages in the deposition excerpt of Dr.
Vouis that she submitted to the Court, so the present record does not
support her assertions.
“Material facts not supported by specific
citation to particular parts of materials in the record . . . will not be
considered by the court.” M.D. Ga. L.R. 56.
4
III. Marian Kaiser (ECF No. 29 in 4:13-cv-464)
Kaiser sought treatment for stress urinary incontinence from
Dr. David Guthman.
May
16,
2005.
Dr. Guthman implanted Kaiser with ObTape on
Kaiser
did
not
see
any
materials
from
Mentor
regarding ObTape, and she did not speak with any representatives
of Mentor about the product.
Kaiser asserts that she suffered
various injuries caused by ObTape.
Kaiser asserts that Mentor misrepresented to Dr. Guthman (or
concealed from him) an accurate complication rate for ObTape, the
severity of known ObTape complications, and true information about
ObTape’s physical characteristics.
ECF No. 31-3.
E.g., Guthman Dep. 42:8-43:22,
She also pointed to evidence that if Dr. Guthman
had known the true risks of ObTape, he would not have implanted it
in Kaiser.
patient,
Id. at 38:19-21 (“[I]n pursuit of the health of our
we
possible.”);
always
id.
at
try
to
use
78:14-19
the
safest,
(stating
lowest-risk
that
Dr.
Guthman
device
would
always choose the safer alternative product); id. at 85:17-86:2
(stating
that
if
Mentor
had
provided
him
with
additional
information suggesting that ObTape had a higher risk than other
products, he “would probably have searched out an alternative”).
Kaiser is an Illinois resident whose ObTape-related treatment
took place in Illinois.
She filed her action in Hennepin County
District Court of the State of Minnesota and served Mentor with
the Complaint on September 10, 2013.
5
Kaiser brought claims for
strict liability, negligence, breach of express warranty, breach
of implied warranty, common law fraud, constructive fraud, and
negligent and intentional misrepresentation.
IV.
Sandy Anne Hill (ECF No. 29 in 4:13-cv-485)
Hill
saw
Dr.
Clifford
urinary incontinence.
Sarnacki
for
treatment
of
stress
Dr. Sarnacki diagnosed Hill with bladder
prolapse and recommended surgery.
On July 30, 2004, Dr. Sarnacki
implanted Hill with ObTape, although Hill claims that she did not
learn about the implanted device until sometime later.
Hill did
not see any materials from Mentor regarding ObTape, and she did
not speak with any representatives of Mentor about the product.
Hill asserts that the ObTape did not cure her incontinence and
that it caused her abdominal pain.
Hill
appears
to
assert
that
Mentor
misrepresented
to
Dr.
Sarnacki (or concealed from him) an accurate complication rate for
ObTape,
the
information
severity
about
of
ObTape’s
known
ObTape
physical
complications,
characteristics.
and
true
She
also
appears to assert that if Dr. Sarnacki had known the true risks of
ObTape, he would not have implanted it in Hill.
But Hill did not
point the Court to any evidence on this point.2
2
Dr. Sarnacki passed away before his deposition could be taken. Hill did
not point to any evidence that Dr. Sarnacki relied on information from
Mentor in deciding to implant Hill with ObTape or that he would have made
a different decision if he had been given different information.
The
Court cannot speculate as to what Dr. Sarnacki might have said had he
been able to testify.
6
Hill is a Texas resident whose ObTape-related treatment took
place in Texas.
Court
of
the
She filed her action in Hennepin County District
State
of
Minnesota
Complaint on September 27, 2013.
liability,
implied
negligence,
warranty,
breach
common
served
Mentor
with
the
Hill brought claims for strict
of
law
and
express
fraud,
warranty,
constructive
breach
fraud,
of
and
negligent and intentional misrepresentation.
V.
Barbara Burt (ECF No. 27 in 4:14-cv-60)
Burt sought treatment for stress urinary incontinence from
Dr. Thomas Truluck.
April
24,
2006.
Dr. Truluck implanted Burt with ObTape on
Burt
did
not
see
any
materials
from
Mentor
regarding ObTape, and she did not speak with any representatives
of
Mentor
about
the
product.
Burt
asserts
that
she
suffered
various injuries caused by ObTape.
Before he implanted Burt with ObTape, Dr. Truluck received
training from Mentor and reviewed the ObTape product information
data
sheet.
Truluck
Dep.
26:6-17,
ECF
No.
29-3.
A
Mentor
representative told Dr. Truluck that the approach for implanting
ObTape was a new and safer approach.
Dr. Truluck testified that
if he had known that ObTape had a higher rate of extrusion than
other slings, he would not have implanted Burt with it.
Id. at
42:3-9.
Burt
is
a
North
Carolina
resident
treatment took place in North Carolina.
7
whose
ObTape-related
She filed her action in
Hennepin
served
County
Mentor
District
with
the
Court
of
Complaint
the
on
State
of
February
3,
Minnesota
2014.
and
Burt
brought claims for strict liability, negligence, breach of express
warranty,
breach
constructive
of
implied
warranty,
common
and
negligent
and
fraud,
law
fraud,
intentional
misrepresentation.
VI.
Leslie Alexander (ECF No. 27 in 4:14-cv-62)
Dr.
Thomas
Phillips
September 27, 2004.
Mentor
regarding
representatives
of
implanted
Alexander
with
ObTape
on
Alexander did not see any materials from
ObTape,
Mentor
and
she
about
did
the
not
speak
product.
Dr.
with
any
Phillips
testified that if he had known that ObTape had a higher rate of
infection than other slings, he would not have implanted ObTape in
his patients.
Phillips Dep. 20:9-19, ECF No. 29-3.
Alexander suffered recurrent incontinence in 2007 and sought
treatment from Dr. Roberto Ferraro in 2008.
Dr. Ferraro conducted
exploratory surgery in June 2008 and discovered that Alexander’s
ObTape had eroded through her vaginal wall.
the
portion
of
ObTape
that
he
could
Dr. Ferraro removed
remove.
Alexander
acknowledges that Dr. Ferraro told her in 2008 that she suffered a
vaginal erosion of the ObTape. Alexander Dep. 21:21-22:9, ECF 275.
Alexander contends that she did not connect her complications
to ObTape until she saw a television commercial regarding mesh
injuries in 2013.
8
Alexander is a North Carolina resident whose ObTape-related
treatment took place in North Carolina.
She filed her action in
Hennepin
State
County
District
Court
of
the
of
Minnesota
served Mentor with the Complaint on February 3, 2014.
and
Alexander
brought claims for strict liability, negligence, breach of express
warranty,
breach
constructive
of
implied
warranty,
common
and
negligent
and
fraud,
law
fraud,
intentional
misrepresentation.
DISCUSSION
Each Plaintiff filed her action in Minnesota state court, and
Mentor
removed
each
Plaintiff’s
action
to
the
District Court for the District of Minnesota.
later
transferred
to
this
Court
as
part
litigation proceeding regarding ObTape.
purposes
of
summary
Plaintiffs’ claims.
judgment
that
of
United
States
The cases were
a
multidistrict
The parties agree for
Minnesota
law
applies
to
See In re Mentor Corp. ObTape Transobturator
Sling Prods. Liab. Litig., No. 4:08-md-2004, 2013 WL 286276, at *7
(concluding that Minnesota law applied to claims of non-Minnesota
ObTape plaintiffs who brought their actions in Minnesota).
I.
Strict Liability Claims
Mentor contends that Bromley and Alexander’s strict liability
claims
are
time-barred
under
Minnesota
law.
The
statute
limitations for a strict liability claim is four years.
Stat.
§ 541.05
subd.
2
(“[A]ny
9
action
based
on
the
of
Minn.
strict
liability of the defendant and arising from the manufacture, sale,
use or consumption of a product shall be commenced within four
years.”).
Under
Minnesota
law,
“a
claim
involving
personal
injuries allegedly caused by a defective product accrues when two
elements are present: ‘(1) a cognizable physical manifestation of
the disease or injury, and (2) evidence of a causal connection
between the injury or disease and the defendant’s product, act, or
omission.’”
Klempka v. G.D. Searle & Co., 963 F.2d 168, 170 (8th
Cir. 1992) (quoting Hildebrandt v. Allied Corp., 839 F.2d 396, 398
(8th Cir. 1987)) (applying Minnesota law).
“A plaintiff who is aware of both her injury and the likely
cause of her injury is not permitted to circumvent the statute of
limitations by waiting for a more serious injury to develop from
the same cause.”
suffered
injuries
Id.
and
For example, in Klempka, the plaintiff
was
diagnosed
with
chronic
pelvic
inflammatory disease, which her doctor said was caused by the
plaintiff’s intrauterine device. Id. at 169. Several years later,
the
plaintiff
intrauterine
was
device
told
that
caused
she
her
was
infertile
infertility.
and
Id.
that
the
Applying
Minnesota law, the Eighth Circuit concluded that the plaintiff’s
cause of action accrued when she first learned that she had an
injury (chronic pelvic inflammatory disease) that was caused by
the intrauterine device.
Id. at 170.
10
Bromley cannot seriously deny that she knew she suffered some
injuries caused by ObTape in September 2008 when Dr. Ruhe told
Bromley that her pain was caused by the exposed ObTape.
And
Alexander cannot seriously dispute that she knew she suffered some
injuries caused by ObTape in June 2008 when Dr. Ferraro told her
that her ObTape had eroded through her vaginal wall.
argues,
consulted
however,
a
that
different
her
claims
doctor
not
accrue
until
she
2011
in
did
and
learned
that
the
remainder of her ObTape would have to be removed.
asserts
that
her
claims
did
Bromley
not
accrue
And Alexander
until
she
saw
an
advertisement regarding mesh injuries in 2013.
Bromley
and
Alexander
did
not
point
to
any
Minnesota
authority holding that a plaintiff must be on actual notice that
her
specific
precedent
injuries
establishes
were
that
caused
a
by
claim
a
defect.
accrues
when
Rather,
the
the
plaintiff
becomes aware of an injury and a causal connection between the
injury and the defendant’s product.
Bromley
and
Alexander
Klempka, 963 F.2d at 170.
nonetheless
contend
that
one
Eighth
Circuit case and one Minnesota District Court case support denial
of summary judgment in this case. The Court disagrees. First, they
point to Tuttle v. Lorillard Tobacco Co., 377 F.3d 917 (8th Cir.
2004). In Tuttle, the district court found that the decedent’s
smokeless
tobacco
decedent
discovered
product
a
lump
liability
in
his
11
action
cheek.
accrued
The
when
Eighth
the
Circuit
reversed because the decedent’s doctor initially told the decedent
that the lump was caused by an oral infection and was treatable
with
antibiotics—not
tobacco.
Id.
at
that
922.
it
was
Second,
oral
Bromley
cancer
and
caused
Alexander
by
the
point
to
Huggins v. Stryker Corp., 932 F. Supp. 2d 972 (D. Minn. 2013).
In
Huggins, the plaintiff asserted that the defendant’s pain pump
caused a condition that resulted in degeneration of his cartilage.
The plaintiff’s doctor discovered the loss of cartilage in 2002,
but he did not connect the condition to the pain pump or tell the
plaintiff that there was such a connection.
The district court
noted that the “first article recognizing a potential causal link
between
pain
published
pumps”
until
and
2007.
the
plaintiff’s
Id.
Tuttle
and
condition
Huggins
distinguishable from Bromley and Alexander’s cases.
Tuttle
and
Huggins,
there
is
no
dispute
was
that
are
not
both
Unlike in
Bromley
and
her
doctor connected Bromley’s injuries to ObTape in September 2008,
and there is no dispute that Alexander and her doctor connected
Alexander’s injuries to ObTape in June 2008.
Bromley
and
Alexander
argue
that
even
if
Minnesota’s
discovery rule does not save their strict liability claims, the
statute of limitations should be tolled by fraudulent concealment.
“Fraudulent concealment, if it occurs, will toll the running of
the
statute
of
limitations
until
discovery
or
reasonable
opportunity for discovery of the cause of action by the exercise
12
of due diligence.”
Holstad v. Sw. Porcelain, Inc., 421 N.W.2d
371, 374 (Minn. Ct. App. 1988); accord Hydra-Mac, Inc. v. Onan
Corp.,
450
N.W.2d
fraudulent
913,
concealment
918
(Minn.
has
the
1990).
burden
“The
of
party
showing
claiming
that
the
concealment could not have been discovered sooner by reasonable
diligence
on
negligence.”
his
part
and
was
not
the
result
of
his
Wild v. Rarig, 234 N.W.2d 775, 795 (Minn. 1975).
own
As
discussed above, Dr. Ruhe told Bromley in September 2008 that her
pain was caused by ObTape and that the mesh “shouldn’t have been
falling out.”
Bromley Dep. 105:18-106:4.
And Dr. Ferraro told
Alexander in June 2008 that her ObTape had eroded through her
vaginal wall.
A reasonable person in that situation would take
some action to follow up on the cause of her injuries and try to
find
out
whether
the
injuries
were
caused
by
a
problem
with
ObTape, a problem with the implant surgery, or some other problem.
But Bromley and Alexander pointed to no evidence that they took
any action to investigate their potential claims even though they
knew there was a connection between their injuries and the ObTape.
Under
these
circumstances,
the
Court
concludes
that
fraudulent
concealment does not toll the statute of limitations.
Bromley’s
strict liability claim accrued in September 2008, and Alexander’s
accrued in June 2008.
years of the accrual.
Neither filed her Complaint within four
The strict liability claims of Bromley and
Alexander are therefore time-barred.
13
II.
Misrepresentation and Common Law Fraud Claims
Larranaga, Kaiser, Hill, Burt, and Alexander assert claims
for common law fraud, negligent misrepresentation, and intentional
misrepresentation.
Mentor seeks summary judgment on these claims,
contending that Minnesota law requires each Plaintiff to prove
that she was injured because she relied on a misrepresentation
from Mentor.
But under Minnesota law, a misrepresentation claim
in a medical device case can be premised on the manufacturer’s
alleged
misrepresentations
misrepresentations
directly
to
to
the
a
physician—not
patient.
Kociemba
just
v.
G.D.
Searle & Co., 707 F. Supp. 1517, 1525 (D. Minn. 1989); accord In
re Minnesota Breast Implant Litig., 36 F. Supp. 2d 863, 879 (D.
Minn. 1998) (“Statements made by a pharmaceutical representative
directly to a physician should be expected to be relied upon[.]”).
Thus, if a plaintiff can establish that the manufacturer made
misrepresentations
to
her
physician
regarding
the
risks
of
a
product and that the physician would not have recommended the
product for the plaintiff had he known the product’s true risks,
then the reliance and causation elements are satisfied.3
3
Mentor
seeks
summary
judgment
on
Plaintiffs’
“negligent
misrepresentation” claims because Minnesota has not expressly recognized
the tort of negligent misrepresentation involving the risk of physical
harm.
See Smith v. Brutger Cos., 569 N.W.2d 408, 413 (Minn. 1997)
(declining to recognize the tort of negligent misrepresentation with
physical harm but stating that the decision did “not foreclose the
possibility of recognizing
in
Minnesota
the tort of negligent
misrepresentation involving the risk of physical harm” under a different
factual
scenario—with
an
actionable
misrepresentation,
reasonable
reliance, and a causal connection).
In support of their “negligent
14
Here,
them
and
Plaintiffs
induce
assert
them
to
that
Mentor,
undergo
the
intending
ObTape
to
defraud
procedure,
made
misrepresentations to their physicians that induced the physicians
to recommend ObTape to Plaintiffs.
Plaintiffs further contend
that they relied on their doctors in deciding to proceed with the
ObTape
procedure.
Kaiser,
Burt,
and
Alexander
each
produced
evidence that their physicians would not have implanted them with
ObTape had they known its true risks.
Thus, for Kaiser, Burt, and
Alexander, the Court is satisfied that a genuine fact dispute
exists on the justifiable reliance and causation elements, and
Mentor is not entitled to summary judgment on their fraud and
misrepresentation claims.
Larranaga and Hill, however, did not point the Court to any
evidence that their physicians relied on a misrepresentation from
Mentor in selecting ObTape or that the physicians would not have
recommended ObTape had they known its true risks.
They contend
that the Court should apply a “heeding presumption”—a “rebuttable
presumption that the injured person would have heeded an adequate
warning, had one been provided,” which Minnesota has recognized in
certain product cases.
Prairie v. Mio Mech. Corp., No. 27-CV-12-
14077, 2013 WL 3869264, at *6 (Minn. Dist. Ct. June 25, 2013).
misrepresentation” claims, Plaintiffs allege that
reasonable care in providing warnings to their
See, e.g., Burt Compl. ¶¶ 100-104, ECF No. 1-1
Plaintiff’s “negligent misrepresentation” claims
warn claims, which Minnesota does recognize, so
grant summary judgment on this basis.
15
Mentor did not exercise
doctors about ObTape.
in 4:14-cv-60.
Thus,
are simply failure to
the Court declines to
For example, in Prairie, the Minnesota trial court presumed that a
window washer who died after falling from the defendant’s roof
rigger platform product would have heeded an adequate instruction
regarding
given.
the
Id.
proper
way
to
secure
the
platform
had
one
been
But all Prairie allows the Court to presume is that
Plaintiffs’ physicians would have paid attention to an additional
warning about the risks of ObTape.
In other words, Prairie allows
the Court to presume that the physicians would have considered the
infection
and
erosion
rates—among
other
considerations—in
determining which product to select for their patients.
do
not,
however,
permit
the
Court
to
speculate
The cases
about
physicians would have weighed the additional warnings.
reason, the heeding presumption does not apply.
how
the
For this
Larranaga and
Hill did not point to sufficient evidence to create a fact dispute
on
reliance
and
causation,
so
Mentor
is
entitled
to
summary
judgment on their misrepresentation and fraud claims.
III. Constructive Fraud Claims
Larranaga,
“constructive
constructive
Kaiser,
fraud”
fraud
Hill,
Burt,
claims.
claims
Mentor
fail
and
Alexander
contends
because
Mentor
that
did
brought
Plaintiffs’
not
owe
a
fiduciary duty to Plaintiffs; under Minnesota law, “[c]onstructive
fraud reposes exclusively in the context of fiduciary obligations
and is simply a characterization of a breach of such a duty.”
16
Perl v. St. Paul Fire & Marine Ins. Co., 345 N.W.2d 209, 213
(Minn. 1984).
The crux of Plaintiffs’ “constructive fraud” claims is that
Mentor
had
certain
intentionally
information
concealed
it
about
from
the
risks
Plaintiffs’
of
ObTape
physicians.
e.g., Burt Compl. ¶¶ 92-98, ECF No. 1-1 in 4:14-cv-60.
but
See,
In other
words, Plaintiffs are asserting a classic fraudulent concealment
claim, which is recognized under Minnesota law.
N.W.2d at 350
See Flynn, 627
(“Under Minnesota law, fraudulent misrepresentation
based on the concealment of a material fact occurs when one party
knowingly conceals a material fact that is ‘peculiarly within his
own knowledge,’ and the other party relies on the presumption that
the fact does not exist.”) (quoting Richfield Bank & Trust Co. v.
Sjogren, 309 Minn. 362, 364, 244 N.W.2d 648, 650 (1976)).
As discussed above, Kaiser, Burt, and Alexander each produced
evidence that their physicians would not have implanted them with
ObTape had they known its true risks, which Mentor concealed from
them.
Therefore, the Court denies summary judgment as to their
fraudulent concealment claims.
But Larranaga and Hill did not
point to sufficient evidence of causation and reliance, so Mentor
is entitled to summary judgment on their fraudulent concealment
claims.
17
IV.
Breach of Warranty Claims
Larranaga, Kaiser, Hill, Burt, and Alexander brought breach
of warranty claims.
time-barred.
Mentor contends that the warranty claims are
Larranaga,
Kaiser,
Burt,
and
Alexander
do
not
contest summary judgment as to their breach of warranty claims, so
Mentor’s motion as to those claims is granted.
Hill
claims.
contests
summary
judgment
on
her
breach
of
Mentor argues that her claims are time-barred.
warranty
But even
if Hill’s breach of warranty claims are not time-barred, Hill’s
breach of warranty claims fail for the same reasons her fraud and
misrepresentation claims fail: Hill did not point to any evidence
that any breach of warranty by Mentor caused her injuries.
“To
establish a warranty claim the plaintiff must basically prove: the
existence of a warranty, a breach, and a causal link between the
breach and the alleged harm.”
Daigle v. Ford Motor Co., 713 F.
Supp. 2d 822, 825 (D. Minn. 2010) (quoting Peterson v. Bendix Home
Sys., Inc., 318 N.W.2d 50, 52–3 (Minn. 1982)).
Hill did not point
to any evidence that Mentor made warranties directly to her.
She
also did not point to any evidence of a causal link between any
representation Mentor made to Dr. Sarnacki and the alleged harm to
Hill.
The Court thus concludes that Mentor is entitled to summary
judgment on Hill’s breach of warranty claims.
18
CONCLUSION
As discussed above, the Court makes the following rulings on
Mentor’s partial summary judgment motions:
Lisa Bromley.
Mentor’s motion for summary judgment (ECF No.
45 in 4:13-cv-17) is granted.
Only Bromley’s negligence claim
remains pending for trial.
Maria
Larranaga.
Mentor’s
motion
for
judgment (ECF No. 29 in 4:13-cv-339) is granted.
partial
summary
Only Larranaga’s
negligence and strict liability claims remain pending for trial.
Marian Kaiser.
Mentor’s motion for summary judgment (ECF No.
29 in 4:13-cv-464) is granted as to Kaiser’s breach of warranty
claims.
Mentor’s motion is denied as to Kaiser’s intentional
misrepresentation,
fraudulent
negligent
concealment
misrepresentation,
claims.
Those
claims,
fraud,
along
with
and
her
strict liability and negligence claims, remain pending for trial.
Sandy Anne Hill.
Mentor’s motion for summary judgment (ECF
No. 29 in 4:13-cv-485) is granted.
Only Hill’s negligence and
strict liability claims remain pending for trial.
Barbara Burt.
27
in
4:14-cv-60)
claims.
Mentor’s
misrepresentation,
fraudulent
Mentor’s motion for summary judgment (ECF No.
is
granted
motion
is
negligent
concealment
as
to
denied
Burt’s
as
to
breach
Burt’s
misrepresentation,
claims.
Those
claims,
of
warranty
intentional
fraud,
along
with
and
her
strict liability and negligence claims, remain pending for trial.
19
Leslie Alexander.
No.
27
in
Mentor’s motion for summary judgment (ECF
4:14-cv-62)
is
granted
as
to
liability claim and breach of warranty claims.
Alexander’s
strict
Mentor’s motion is
denied as to Alexander’s intentional misrepresentation, negligent
misrepresentation,
fraud,
and
fraudulent
concealment
claims.
Those claims, along with her negligence claim, remain pending for
trial.
Within seven days of the date of this Order, the parties
shall notify the Court whether the parties agree to a Lexecon
waiver.
IT IS SO ORDERED, this 19th day of November, 2015.
S/Clay D. Land
CLAY D. LAND
CHIEF U.S. DISTRICT COURT JUDGE
MIDDLE DISTRICT OF GEORGIA
20
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?